Duodenal neuroendocrine tumors
نویسنده
چکیده
5. Howe JR, Klimstra DS, Maccia RD et al. Factors predictive of survival in ampullaty carcinoma. Ann Surg 1998; 228: 87-94. 6. Talamini MA, Moesinger RC, Pitt HA et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-599. 7. AIlema JH, Reinders ME, van Gulik TM at al. Results of pancreaticoduodenectomy for ampullaty carcinoma and analysis ofprognostic factors forsurvival. Surgery 1995; 117: 247-253 8. Klempnauer J, Ridder GJ, Pichimayr R. Prognostic factors after resection of ampullary carcinoma: Multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg 1995; 82: 1686-1691. 9. Neoptolemos JP, Talbot IC, Shaw DC at al. Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 1988; 61: 1403-1407. 10. Roder JD, Schneider PM, Stein HJ at al. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater Br J Surg 1995; 82:1693-1696. 11. Baczako K, Buchier M, Berger HG at al. Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater Epithellal dysplasia and adenoma. Hum Pathol 1985; 16: 305-310. 12. Kimura W, Ohtsubo K. Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer 1988; 61: 1394-1402. 13. Boa JL. The ras gene family and human carcinogenesis. Mutation Res 1988; 195: 255-271. 14. Howe JR. Klimstra OS, Cordon-Cardo Cat al. K-ras mutation in adenomas and carcinomas of the ampulla of Vater Olin Cancer Res 1997; 3:129-133. 15. Scarpa A, Zamboni G, Achille A at al. Ras-family gene mutations in neoplasia of the ampulla of Vater. lot J Cancer 1994; 59: 39-42. 16. Sessa F, Solcia E, Capella C at al. Intraductal papillary-mucinous pancreatic tumors are phenotypically, genetically and behaviorally distinct growths. An analysis of tumor cell phenotype, K-ras and p58 genes’ mutations. Virchows Arch 1994; 425: 357-367. 17. Nishisho I, Nakamura Y, MiyoshiY etal. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-669. 18. Achille A, Scupoli MT, Magalini AR at al. APC gene mutations and allelic lossas in sporadic ampullary tumours. lot J Cancer 1996; 68: 305-312. 19. Toyooka, M., Konishi, M., Kikuchi-Yanoshita at al. Somatic mutations of the adenomatouspolyposis coli gene in gastroduodenal tumors from patients with tamilial adenomatous polyposis. Cancer Res 1995; 55: 3165-3170. 20. lonov Y, Pineado MA, Malkhosyan S at al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism forcolonic carcinogenesis. Nature 1993; 363: 558-561. 21. Perucho M. Microsatellite instability: The mutator that mutates the other mutator. Nature Med 1996; 2:630-631.
منابع مشابه
Endoscopic resection of duodenal bulb neuroendocrine tumor larger than 10 mm in diameter
BACKGROUND Endoscopic treatment for duodenal bulb neuroendocrine tumor larger than 10 mm is still controversial. This report presents four cases successfully treated with endosonography (EUS)-assisted endoscopic mucosal resection (EMR) procedure for duodenal bulb neuroendocrine tumor larger than 10 mm in diameter. METHODS The case series of four patients diagnosed with neuroendocrine tumor fr...
متن کاملDigestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
BACKGROUND Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) are relatively rare tumors, not equally distributed in the gastrointestinal system. In 2010, a revised version of the WHO classification of GEP-NENs was published. This study reports for the first time the distribution and characteristics of GEP-NENs in a Lebanese population. MATERIALS AND METHODS This descriptive retrospe...
متن کاملEndoscopic Treatment of Duodenal Neuroendocrine Tumors
Duodenal neuroendocrine tumors (NETs) are rare neoplasms. In this study, the medical records of 14 patients with duodenal NETs diagnosed at Chonnam National University Hospital from July 2001 to August 2011 were reviewed and analyzed retrospectively. Four patients were diagnosed in the first 5 years, and 10 patients were diagnosed in the latter 5 years of the study. Ten of 12 patients (83.3%) w...
متن کاملNeuroendocrine Tumors of the Gi and Pancreatobiliary Tract
1. Incipient neuroendocrine neoplasia: Dysplasia/Tis 2. True neuroendocrine tumors a. Well differentiated NETs (carcinoids, pancreatic neuroendocrine neoplasms) b. High-grade neuorendocrine carcinoma 3. Hybrid tumors a. Mixed tumors i. Mixed adenocarcinoma-neuorendocrine carcinoma ii. Mixed neuorendocrine tumor and non-neuroendocrine carcinoma iii. Duodenal gangliocytic paraganglioma b. Inciden...
متن کاملLate anastomotic perforation following surgery for gastric neuroendocrine tumor complicated by perforated duodenal ulcer: a case report
Neuroendocrine tumors (NETs) are a group of neoplasms that are characterized by the secretion of a variety of hormones and diverse clinical syndromes. NETs are considered to be rare, but the incidence of NETs has increased rapidly in recent years. NETs provide a clinical challenge for physicians because they comprise a heterogeneous group of malignancies with a wide range of morphological, func...
متن کاملDuodenal somatostatinoma: a case report and review of the literature
INTRODUCTION About 70% of well-differentiated endocrine tumors arise from the gastrointestinal tract. Duodenal well-differentiated endocrine tumors account for only 2.6% of all neuroendocrine tumors. Following the first two case reports of somatostatin-secreting tumors in 1977, fewer than 200 cases of somatostatinoma have been reported. These tumors of the duodenum are usually silent and asympt...
متن کامل